Anika Therapeutics Inc (ANIK)

Cash & Equivalents

$38.41M

Quarterly · Period ending: · USD

ANIK logo

ANIK Cash & Equivalents

Latest reported$38.41M
ANIK Quarterly Cash & Equivalents ($5.40M → $38.41M)
High-resolution chart · PNG

ANIK cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
38,412,000
41,020,000
57,481,000
57,990,000
53,167,000
53,371,000
55,629,000
62,368,000
62,822,000
68,629,000
68,740,000
70,651,000
65,071,000
79,737,000
86,327,000
87,777,000
91,392,000
90,325,000
94,386,000
90,976,000
97,181,000
94,599,000
95,817,000
104,216,000
116,746,000
65,833,000
157,463,000
103,381,000
69,407,000
95,514,000
89,042,000
81,825,000
126,047,000
141,797,000
133,256,000
126,960,000
117,874,000
119,368,000
104,261,000
98,047,000
89,125,000
92,837,000
110,707,000
108,469,021
103,920,222
99,802,205
100,155,864
71,772,194
84,879,562
82,160,251
63,333,160
64,055,438
54,140,459
50,965,566
44,067,477
39,855,856
37,909,608
34,003,178
35,777,222
29,048,664
26,829,029
29,078,810
28,201,932
25,765,924
23,648,822
23,167,641
24,426,990
38,540,295
39,549,558
40,426,703
43,193,655
35,368,244
37,297,479
38,953,354
35,903,569
46,159,638
44,751,227
43,780,878
47,167,432
47,420,450
46,127,054
44,459,721
44,747,000
45,872,000
39,930,000
40,337,000
39,339,000
34,003,000
33,536,000
34,499,000
14,592,000
12,611,000
11,453,000
10,490,000
11,001,596
7,201,085
7,477,859
10,447,648
9,064,977
10,001,142
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.